However, a 2007 study evaluating HER2 staining in 320 ovarian cancer samples identified only 15 (4.7 %) tumors with 3 + staining and 26 tumors (8.1 %) with 2 + staining (Tuefferd et al., 2007). The gene discussed is ERBB2; the disease is ovarian cancer.